drugset / Trial / NCT01313962
Safety Study of Flufirvitide-3 Nasal Spray in Healthy Subjects
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to evaluate the safety and pharmacokinetic profile of flufirvitide-3 nasal spray in healthy subjects.
Timeline
- Start
- 2011-08
- Primary completion
- 2012-01
- Completion
- 2012-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Flufirvitide 3 | Unknown | 0.05 mg | Intranasal |
| Subject | Flufirvitide 3 | Unknown | 0.1 mg | Intranasal |
| Subject | Flufirvitide 3 | Unknown | 0.2 mg | Intranasal |
| Subject | Flufirvitide 3 | Unknown | 0.4 mg | Intranasal |